Ambetter's prior authorization approval rate for Ozempic in 2025 was 62% nationally per Centene's Q4 2025 investor disclosure
3rd-Party Lab Tested: This product is tested by a third-party lab for quality
If you are looking for an alternative to Wegovy, discuss these options with your healthcare provider: Tirzepatide (available as Mounjaro or Zepbound) : Tirzepatide, a GLP-1 receptor agonist, is utilized to manage both type 2 diabetes and obesity
By reducing hunger signals to the brain, slowing digestion so food stays in the stomach longer, and improving insulin sensitivity, these drugs make it easier to eat less, feel full sooner, and maintain more stable blood sugar levels
Additionally, those with gastrointestinal disorders will be evaluated to ensure compatibility with their overall health goals
2 This can make it easier to eat smaller portions while still meeting your nutrition needs